ouabain and 19-hydroxy-5,8,11,14-eicosatetraenoic acid

ouabain has been researched along with 19-hydroxy-5,8,11,14-eicosatetraenoic acid in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Escalante, B; Falck, JR; Schwartzman, ML; Sessa, WC; Yadagiri, P1
Escalante, B; Falck, JR; Laniado-Schwartzman, M; Sun, LM; Yadagiri, P1

Other Studies

2 other study(ies) available for ouabain and 19-hydroxy-5,8,11,14-eicosatetraenoic acid

ArticleYear
Cytochrome P450-dependent arachidonic acid metabolites, 19- and 20-hydroxyeicosatetraenoic acids, enhance sodium-potassium ATPase activity in vascular smooth muscle.
    Journal of cardiovascular pharmacology, 1990, Volume: 16, Issue:3

    Topics: Analysis of Variance; Animals; Aorta, Thoracic; Cytochrome P-450 Enzyme System; Hydroxyeicosatetraenoic Acids; In Vitro Techniques; Indomethacin; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Ouabain; Potassium; Rats; Rats, Inbred Strains; Rubidium Radioisotopes; Sodium-Potassium-Exchanging ATPase

1990
19(S)-hydroxyeicosatetraenoic acid is a potent stimulator of renal Na+-K+-ATPase.
    Biochemical and biophysical research communications, 1988, May-16, Volume: 152, Issue:3

    Topics: Animals; Dose-Response Relationship, Drug; Hydroxyeicosatetraenoic Acids; Kidney Cortex; Microsomes; Ouabain; Rabbits; Rats; Sodium-Potassium-Exchanging ATPase

1988